A Look At The Intrinsic Value Of Nucleus Software Exports Limited (NSE:NUCLEUS)
Key Insights
- Using the 2 Stage Free Cash Flow to Equity, Nucleus Software Exports fair value estimate is ₹982
- Current share price of ₹805 suggests Nucleus Software Exports is potentially trading close to its fair value
- The average premium for Nucleus Software Exports' competitorsis currently 229%
In this article we are going to estimate the intrinsic value of Nucleus Software Exports Limited (NSE:NUCLEUS) by taking the forecast future cash flows of the company and discounting them back to today's value. We will take advantage of the Discounted Cash Flow (DCF) model for this purpose. Believe it or not, it's not too difficult to follow, as you'll see from our example!
Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model.
View our latest analysis for Nucleus Software Exports
Step By Step Through The Calculation
We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
Generally we assume that a dollar today is more valuable than a dollar in the future, so we need to discount the sum of these future cash flows to arrive at a present value estimate:
10-year free cash flow (FCF) estimate
2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | |
Levered FCF (₹, Millions) | ₹1.56b | ₹1.83b | ₹2.11b | ₹2.35b | ₹2.58b | ₹2.81b | ₹3.04b | ₹3.28b | ₹3.52b | ₹3.78b |
Growth Rate Estimate Source | Analyst x1 | Analyst x1 | Analyst x1 | Est @ 11.20% | Est @ 9.86% | Est @ 8.92% | Est @ 8.26% | Est @ 7.80% | Est @ 7.47% | Est @ 7.25% |
Present Value (₹, Millions) Discounted @ 14% | ₹1.4k | ₹1.4k | ₹1.4k | ₹1.4k | ₹1.3k | ₹1.2k | ₹1.2k | ₹1.1k | ₹1.0k | ₹978 |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = ₹12b
We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 6.7%. We discount the terminal cash flows to today's value at a cost of equity of 14%.
Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = ₹3.8b× (1 + 6.7%) ÷ (14%– 6.7%) = ₹52b
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= ₹52b÷ ( 1 + 14%)10= ₹13b
The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is ₹26b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Compared to the current share price of ₹805, the company appears about fair value at a 18% discount to where the stock price trades currently. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.
Important Assumptions
Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Nucleus Software Exports as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 14%, which is based on a levered beta of 1.069. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
SWOT Analysis for Nucleus Software Exports
- Debt is not viewed as a risk.
- Dividends are covered by earnings and cash flows.
- Dividend is in the top 25% of dividend payers in the market.
- Earnings declined over the past year.
- Annual earnings are forecast to grow faster than the Indian market.
- Good value based on P/E ratio and estimated fair value.
- No apparent threats visible for NUCLEUS.
Looking Ahead:
Although the valuation of a company is important, it is only one of many factors that you need to assess for a company. DCF models are not the be-all and end-all of investment valuation. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. For Nucleus Software Exports, we've put together three essential items you should assess:
- Risks: For example, we've discovered 1 warning sign for Nucleus Software Exports that you should be aware of before investing here.
- Future Earnings: How does NUCLEUS's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
- Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered!
PS. Simply Wall St updates its DCF calculation for every Indian stock every day, so if you want to find the intrinsic value of any other stock just search here.
Valuation is complex, but we're here to simplify it.
Discover if Nucleus Software Exports might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NSEI:NUCLEUS
Nucleus Software Exports
Provides lending and transaction banking products to the financial services industry in India, the Far East, South East Asia, Europe, the Middle East, Africa, Australia, and internationally.
Flawless balance sheet with high growth potential and pays a dividend.
Similar Companies
Market Insights
Community Narratives
